Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1327 (14 June), doi:10.1136/bmj.39609.364688.DB
Jeanne Lenzer
1 New York
| The first 150 words of the full text of this article appear below. |
Findings that a leading Harvard professor of psychiatry failed to report substantial payments that he received from drug companies has caused Harvard Medical School, one of its affiliated hospitals, and the US National Institutes of Health (NIH) to come under fire.
An investigation by the US senator Charles Grassley showed that the psychiatrist, Joseph Biederman, and two of his colleagues, Thomas Spencer and Timothy Wilens, had altogether received more than $4.2m (£2.1m;
2.7m) from drug companies since 2000.
The financial disclosure forms filed by the three doctors, according to Mr Grassley, "were a mess" and made it seem that they had received only "a couple of hundred thousand dollars" in the past seven years (http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?dbname=2008_record&page=S5029&position=all).
Mr Grassley said that the failure of the researchers to report their full income could place Harvard and Massachusetts General Hospital "in jeopardy of violating NIH regulations on conflicts of interest." Such violations
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.